Polymer–drug conjugate therapeutics: advances, insights and prospects

Polymer–drug conjugate therapeutics: advances, insights and prospects

Polymer–drug conjugate therapeutics: advances, insights and prospects, Published online: 12 December 2018; doi:10.1038/s41573-018-0005-0

The conjugation of therapeutic agents to polymer carriers, such as polyethylene glycol (PEG), can control drug delivery, enhance solubilization, increase efficacy and improve pharmacokinetics. Here, Grinstaff, Colson and Ekladious discuss recent advances in the preclinical and clinical development of different classes of polymer–drug conjugates and highlight current challenges and future directions.

Articles You May Like

Switch from hunting to herding recorded in ancient urine
Bio-IT World Announces Inaugural Innovative Practices Awards Winners
BRB-seq: The quick and cheaper future of RNA sequencing
New discovery makes fast-charging, better performing lithium-ion batteries possible
Get Paid To Stay In Bed, For Space Science

Leave a Reply

Your email address will not be published. Required fields are marked *